# EXFORGE HCT
> **NDA022314** · New Drug Application · Sponsor: NOVARTIS · Approved 2009-04-30
## Drug
- **FDA Application Number:** NDA022314
- **Application type:** New Drug Application
- **Brand name:** EXFORGE HCT
- **Generic name:** AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2009-04-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022314)
---
*MORVS · CC0 1.0*